Press Release
Global On-Body Drug Delivery Market to Surpass USD 740 Million
Pune, December 5, 2025 – Global Data Route Analytics announces the release of its in-depth report titled “On-Body Drug Delivery Devices Global Market Size & Share 2020–2035: Deep-Dive Trends, Growth Drivers, and Competitive Landscape Forecast Report.” This comprehensive study evaluates the global market's transformative growth driven by innovation in wearable drug delivery technologies.
For a free sample of the report, please contact us here
https://globaldatarouteanalytics.com/report/230/global-on-body-drug-delivery-devices-market/download
Transforming chronic disease treatment paradigms, on-body drug delivery devices offer unprecedented convenience and compliance benefits. With increasing adoption for conditions like diabetes, cardiovascular diseases, and oncology, these technologies are revolutionizing patient outcomes through personalized, self-administered therapies. The report reveals that the market is poised to grow from USD 220 million in 2024 to over USD 740 million by 2032, registering a compelling CAGR of 9.5%.
Key drivers include the rise in home-based care, biologic therapies, and the integration of smart sensors, real-time monitoring, and connectivity-enabled features (Bluetooth/Wi-Fi), boosting uptake in both developed and emerging regions.
For any inquiry related to this report, please click here
https://globaldatarouteanalytics.com/report/230/global-on-body-drug-delivery-devices-market/inquiry
The market is segmented by:
• Product Type: Wearable Injectors, Patch Injectors, Infusion Pumps, Smart Delivery Devices, Others
• Technology: Mechanical, Electronic, Connectivity-Enabled Devices, Others
• Application: Diabetes, Oncology, Cardiovascular Disorders, Autoimmune Diseases, Pain Management, Infectious Diseases, Others
• End User: Hospitals, Home Care Settings, Specialty Clinics, Ambulatory Surgical Centers, Others
• Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Top players profiled include:
• Amgen Inc., Insulet Corporation, Medtronic plc, Tandem Diabetes Care, Becton Dickinson (BD), West Pharmaceutical Services, Ypsomed AG, Enable Injections, Sensile Medical (Gerresheimer AG), Eoflow, Debiotech, CeQur, Zealand Pharma, Subcuject ApS, Stevanato Group, and others.
The 500-page PDF report also covers market dynamics, COVID-19 impact, pricing analysis, regulatory frameworks, strategic recommendations, and competitive benchmarking.
For discounts related to this report, explore here
https://globaldatarouteanalytics.com/report/230/global-on-body-drug-delivery-devices-market/discount
About the Company
Global Data Route Analytics is a market research and consulting firm that provides businesses with data analysis, market forecasts, and tailored reports across various industries. The company uses advanced data analysis techniques, proprietary data, and an expert team to help clients understand market trends, make informed decisions, and develop strategies. They focus on delivering customized solutions, competitive intelligence, and growth strategies to help businesses succeed in their respective markets.
Media Contact:
Srushti Tungar
Global Data Route Analytics
